Follow-up Study After Investigator-Initiated Phase I Study of MTC001 for Chronic Ischemic Heart Failure.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030230216

Enrollment

Registered

2023-07-11

Start date

2023-07-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic ischemic heart failure

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients who received VCF1 in the investigator-initiated phase 1 study (MTC001-2012) and who have consented to this observational study by the end of study participation (52 weeks). 2)Patients who are able to obtain written consent in person.

Exclusion criteria

Exclusion criteria: 1)Patients who withdrew consent after receiving VCF1 in the investigator-initiated phase I study (MTC001-2012) 2)Patients deemed ineligible by the Principal Investigator or Sub investigator

Design outcomes

Primary

Measure	Time frame
Occurrence of major cardiovascular events *: Major cardiovascular events: death, myocardial infarction, stroke, hospitalization/prolonged hospitalization due to worsening heart failure, cardiac perforation, cardiac tamponade, sustained ventricular tachycardia (>30 seconds or hemodynamic collapse)/ventricular fibrillation among serious adverse events	—

Contacts

Public ContactTakeshi Machino

University of Tsukuba Hospital

machino@md.tsukuba.ac.jp+81-29-853-3143

Outcome results